Hong Kong medical stocks rose in early trading, with Xuanzhu Bio-B up more than 15%.

Hong Kong pharmaceutical stocks rose in early trading, with Stemcyte Biologicals-B up more than 15%, CStone Pharmaceuticals and Sino Biopharmaceutical-B both up more than 5%, and Hutchison China MediTech and BeiGene following suit.